Democritus University of Thrace (DUTH)
Μελέτη της ανθεκτικότητας του Helicobacter pylori έναντι της κλαριθρομυκίνης με τη χρήση μοριακών διαγνωστικών μεθόδων
Abstract
dc:descriptionHelicobacter pylori (H.pylori) was discovered in 1984 by Barry James Marshall and John Robin Warren. It is an S-shaped Gram (-) microaerophilic bacterium with a pouch of 5 to 7 polar-coated flagella. Its global prevalence is up to 50% of the adult population. Although most carriers of the disease remain asymptomatic, a proportion of them may develop gastritis or peptic ulcer, and the infection has been associated with a significant increase in the risk of gastric cancer and MALT lymphoma. First-line treatment for the eradication of H.pylori involves the simultaneous administration of two antibiotics together with a proton pump inhibitor. One of the most common antibiotics used is clarithromycin. The bacterium has the ability to develop resistance to the antimicrobial agents administered and its high rate of resistance to clarithromycin is the main cause of failure of eradication schemes. There are two main methods to determine the antimicrobial resistance. By culturing the bacterium and measuring the minimum inhibitory concentration (MIC) and by using molecular methods (PCR). The use of molecular shows multiple advantages as it is faster and requires less time in the laboratory. Resistance rates do not only vary between countries, but even within the same country. Mapping it locally and limited geographically could help in the management of H.pylori, especially after failed eradication attempts. The aim of this study is to investigate the resistance of H.pylori against clarithromycin using molecular diagnostic methods in the region of Thrace and its possible correlation with factors such as gender and age. Patients referred for upper digestive endoscopy and who had not received eradication therapy in the past were included. Those under 18 years of age and those who had received antibiotics or proton pump inhibitors in the previous three months were excluded. Participants were initially asked to sign an informed consent form and complete an appropriately designed questionnaire. This was followed by gastroscopy and biopsies were taken. All samples were subjected to rapid urease testing and those with a positive result were followed by isolation of genetic material. The next step was to perform real-time PCR for simultaneous detection of H.pylori and the mutations responsible for clarithromycin resistance. Clarithromycin resistance was detected in 23%. Using a generalized linear model, incorporating clarithromycin resistance as an independent variable, sex and age ≥60 as independent variables and symptoms as covariates, it was documented that resistance is independent of both sex (p = 0.504) and age ≥60 (p = 0.792). In addition, we conducted a meta-analysis of 15 recently published studies to compare the results of our study with data from other countries. In China the rate was recorded in three studies to range from 39% to 55%. In countries around the Mediterranean, it was found to vary, 19% in Turkey, 28% in Italy, 44% in Spain and 54% in Israel. The lowest rate of resistance to clarithromycin was recorded in Thailand and the highest in Vietnam.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karvelas, Alexandros
- Καρβέλας, Αλέξανδρος
Subjects
dc:subject × 18- Ελικοβακτηρίδιο του Πυλωρού
- Κλαριθρομυκίνη
- Ανθεκτικότητα
- Helicobacter pylori
- Clarithromycin
- Resistance
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Μικροβιολογία (ιατρική)
- Γαστροεντερολογία
- Άλλες Ιατρικές Επιστήμες
- Ιατρική έρευνα και Πειραματική ιατρική
- Clinical Medicine
- Medical and Health Sciences
- Microbiology (medical)
- Gastroenterology
- Other Medical Sciences
- Research and Experimental medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53956